Wednesday , September 23 2020
Home / SNB & CHF / Covid-19: When will a vaccine be ready? | The Economist

Covid-19: When will a vaccine be ready? | The Economist

Summary:
Around bn is being spent on finding a vaccine for coronavirus—it’s not nearly enough. And even when a covid-19 vaccine is found how should it be distributed fairly? Our experts answer your questions.00:50 - Will there ever be a “silver-bullet” vaccine? 01:41 - How long would it take for the whole world to be vaccinated? 02:25 - Who benefits financially from the vaccine? 03:54 - How much will each vaccine cost? 05:10 - What percentage of Americans do you estimate will choose not to get vaccinated, and how much of an issue will this be? 06:44 - In an ideal world, how should a vaccine be optimally distributed? 07:21 - Will new versions of the vaccine be required periodically? 07:54 - Will developing countries receive equal access to the vaccine, or will

Topics:
The Economist considers the following as important:

This could be interesting, too:

The Economist writes The Economist Essentials: Public Debt | The Economist

The Economist writes China v America: why universities are on the front line | The Economist

The Economist writes Election 2020: what a Biden victory could mean for America | The Economist

The Economist writes Olympic champion Edwin Moses on covid-19, race and trans athletes | The Economist Podcasts

Around $10bn is being spent on finding a vaccine for coronavirus—it’s not nearly enough. And even when a covid-19 vaccine is found how should it be distributed fairly? Our experts answer your questions.

00:50 - Will there ever be a “silver-bullet” vaccine?
01:41 - How long would it take for the whole world to be vaccinated?
02:25 - Who benefits financially from the vaccine?
03:54 - How much will each vaccine cost?
05:10 - What percentage of Americans do you estimate will choose not to get vaccinated, and how much of an issue will this be?
06:44 - In an ideal world, how should a vaccine be optimally distributed?
07:21 - Will new versions of the vaccine be required periodically?
07:54 - Will developing countries receive equal access to the vaccine, or will they be left behind?
08:50 - Should richer countries pay for vaccines in the developing world?
10:01 - How should we respond to crises like this one in the future?

Further reading:

Find The Economist’s most recent coverage of covid-19 here: https://econ.st/3iwmMMH

Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 coverage: https://econ.st/2Ckne0X

Listen to “The Intelligence” podcast about the vaccine candidates and equitable distribution: https://econ.st/3aqh4Jl

How the world can think better about catastrophic and existential risks: https://econ.st/2CqYN28

Read our leader on how people must adapt to living in the covid-19 pandemic era: https://econ.st/3gSw0SS

How SARS-CoV-2 causes disease and death in covid-19: https://econ.st/33S1jcU

Covid-19 testing labs are being overwhelmed: https://econ.st/3iDGMx1

How the pandemic has shown the urgency of reforming care for the elderly: https://econ.st/2XUqfgh

Read about the hunt for the origins of covid-19: https://econ.st/3iAoX1L


Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *